Inhibition of Neurotoxic Secretory Phospholipases A<sub>2</sub> Enzymatic, Edematogenic, and Myotoxic Activities by Harpalycin 2, an Isoflavone Isolated from <i>Harpalyce brasiliana</i> Benth

<table>Panoramic (a) and detailed (b) view of the best docking solution obtained with the 1PSH (Naja) target. Important residues, directly involved in intermolecular interactions with the inhibitor (harpalycin 2), are labeled. The Ca<sup>2+</sup> atom of the catalytic center was also represented in the figure.</table>

Evidence-Based Complementary and Alternative Medicine

fig7

Figure 7

Figure 7: Inhibition of Neurotoxic Secretory Phospholipases A<sub>2</sub> Enzymatic, Edematogenic, and Myotoxic Activities by Harpalycin 2, an Isoflavone Isolated from <i>Harpalyce brasiliana</i> Benth 

Figure 7 | Inhibition of Neurotoxic Secretory Phospholipases A2 Enzymatic, Edematogenic, and Myotoxic Activities by Harpalycin 2, an Isoflavone Isolated from Harpalyce brasiliana Benth 